An in vivo animal model of chronic arterial occlusion and use of of collagenase to facilitate guide wire crossing in cronic arterial occlusions

Details for Australian Patent Application No. 2002328729 (hide)

International Classifications

Event Publications

30 January 2003 Complete Application Filed

Priority application(s): 60/325,539 01.10.01 US

26 June 2003 Application Open to Public Inspection

Published as AU-B-2002328729

27 October 2005 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 30 Mar 2004

16 July 2009 Application Accepted

Published as AU-B-2002328729

30 July 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 29 Jun 2009. Address for service in Australia - Fisher Adams Kelly 29/12 Creek Street Brisbane QLD 4000 2003

13 August 2009 Application for Amendment

The nature of the amendment is: Amend the invention title to read Use of collagenase to facilitate guide wire crossing in total arterial occlusions. Address for service in Australia - Fisher Adams Kelly 29/12 Creek Street Brisbane QLD 4000 2003

26 November 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 29 Jun 2009 2003

10 December 2009 Amendment Made

The nature of the amendment is: Amend the invention title to read Use of collagenase to facilitate guide wire crossing in total arterial occlusions 2003

17 December 2009 Standard Patent Sealed

8 March 2012 Assignment Registered

Strauss, Bradley The patent has been assigned to Matrizyme Pharma Corporation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.